The Clinical Efficacy of Specially-made “Yinchen Chaiping Tang” Decoction in Treating Chronic Hepatitis B_West China Medical Journal

Authors：

GAO Feng , LUuml

Chengdu Infectious Disease Hospital, Chengdu, Sichuan 610061, P. R. China;

Corresponding author：

Keywords：

茵陈柴平汤; 慢性乙型肝炎，重度; 疗效观察

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的　观察茵陈柴平汤治疗重度慢性乙型肝炎的疗效及不良反应。方法　2009年3月－2010年3月，选择采用茵陈柴平汤联合常规保肝药物治疗50例重度慢性乙型肝炎患者（治疗组），并与50例仅用常规保肝药物治疗的重度慢性乙型肝炎患者（对照组）进行比较，观察治疗2、4周时的临床症状、肝功能及凝血酶原活动度等指标的变化。结果　治疗2、4周时，治疗组在肝功能及凝血酶原活动度等指标均有显著改善，无严重不良反应；4周时，治疗组的症状缓解率（84%）明显高于对照组（66%）；其总有效率（96%）亦高于对照组（80%）。结论　茵陈柴平汤治疗重度慢性乙型肝炎具有较好的临床疗效，且无严重不良反应。

Citation： GAO Feng,LUuml,Yi. The Clinical Efficacy of Specially-made “Yinchen Chaiping Tang” Decoction in Treating Chronic Hepatitis B. West China Medical Journal, 2012, 27(6): 870-872. doi: Copy

1.	中华医学会肝病学分会、传染病学分会. 慢性乙型肝炎防治指南[J]. 中华肝脏病杂志, 2005, 13(12): 881-891.
2.	中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志, 2000, 8(6): 342-329.
3.	Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11): 1118-1129.
4.	World Health Organization. Hepatitis B (Revised August 2008)(2010-12-09)[2011-09-24].[EB/OL]. http://www.who.int/medicacentre/fact-sheets/fs204/en/.
5.	European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B[J]. J Hepatol, 2009, 50 (2): 227-242.
6.	Liu Y, Wang CM, Cheng J, et al. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility[J]. Chin Med J (Engl) 2009,122 (13): 1585-1586.
7.	Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepatitis, 2004, 11 (2): 97-107.
8.	叶任高. 内科学[M]. 6版. 北京: 人民卫生出版社, 2003: 303.
9.	戴万亨. 中西医临床内科学[M]. 北京: 中国医药科技出版社, 2003: 39-41.
10.	王伯祥. 慢性乙型肝炎中医药证治研究进展[J]. 世界中医药, 2007, 1(2): 61-62.
11.	《中医药创新与发展》编委会. 中医药防治在重大传染病的研究[M]. 成都:四川科学技术出版社, 2010: 105-240.

1. 　中华医学会肝病学分会、传染病学分会. 慢性乙型肝炎防治指南[J]. 中华肝脏病杂志, 2005, 13(12): 881-891.
2. 　中华医学会传染病与寄生虫病学分会、肝病学分会. 病毒性肝炎防治方案[J]. 中华肝脏病杂志, 2000, 8(6): 342-329.
3. 　Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences[J]. N Engl J Med, 2004, 350(11): 1118-1129.
4. 　World Health Organization. Hepatitis B (Revised August 2008)(2010-12-09)[2011-09-24].[EB/OL]. http://www.who.int/medicacentre/fact-sheets/fs204/en/.
5. 　European Association For The Study Of The Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B[J]. J Hepatol, 2009, 50 (2): 227-242.
6. 　Liu Y, Wang CM, Cheng J, et al. Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility[J]. Chin Med J (Engl) 2009,122 (13): 1585-1586.
7. 　Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures[J]. J Viral Hepatitis, 2004, 11 (2): 97-107.
8. 　叶任高. 内科学[M]. 6版. 北京: 人民卫生出版社, 2003: 303.
9. 　戴万亨. 中西医临床内科学[M]. 北京: 中国医药科技出版社, 2003: 39-41.
10. 　王伯祥. 慢性乙型肝炎中医药证治研究进展[J]. 世界中医药, 2007, 1(2): 61-62.
11. 　《中医药创新与发展》编委会. 中医药防治在重大传染病的研究[M]. 成都:四川科学技术出版社, 2010: 105-240.

West China Medical Journal

The Clinical Efficacy of Specially-made “Yinchen Chaiping Tang” Decoction in Treating Chronic Hepatitis B

Abstract Full text Figures/Tables Video References Cited by

Format

Content